Giovanni Chillemi

Prof. Giovanni Chillemi

Tuscia University, Viterbo, Italy
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2011 in Inorganic Chemistry
Verified
Journal Article
Closed access
PDPaola D’Angelo
Paola D’Angelo
AZAndrea Zitolo
Andrea Zitolo
VMValentina Migliorati
Valentina Migliorati
GCGiovanni Chillemi
Giovanni Chillemi
MDMagali Duvail
Magali Duvail
RSRiccardo Spezia
Riccardo Spezia

26 October 2020 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
LMLuigi Mansi
Luigi Mansi
MTMarco Antonio Tangaro
Marco Antonio Tangaro
CGClaudio Lo Giudice
Claudio Lo Giudice
TFTiziano Flati
Tiziano Flati
EKEli Kopel
Eli Kopel
Ernesto PicardiErnesto Picardi
Ernesto Picardi
RNA editing is a relevant epitranscriptome phenomenon able to increase the transcriptome and proteome diversity of eukaryotic organisms. ADAR mediated RNA editing is widespread in humans in which millions of A-to-I changes modify thousands of primary transcripts. RNA editing has pivotal roles in the regulation of gene expression or modulation of the innate immune response or functioning of several neurotransmitter receptors. Massive transcriptome sequencing has fostered the research in this field. Nonetheless, different aspects of the RNA editing biology are still unknown and need to be elucidated. To support the study of A-to-I RNA editing we have updated our REDIportal catalogue raising its content to about 16 millions of events detected in 9642 human RNAseq samples from the GTEx project by using a dedicated pipeline based on the HPC version of the REDItools software. REDIportal now allows searches at sample level, provides overviews of RNA editing profiles per each RNAseq experiment, implements a Gene View module to look at individual events in their genic context and hosts the CLAIRE database. Starting from this novel version, REDIportal will start collecting non-human RNA editing changes for comparative genomics investigations. The database is freely available at http://srv00.recas.ba.infn.it/atlas/index.html.

7 February 2002 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
PDPaola D’Angelo
Paola D’Angelo
VBVincenzo Barone
Vincenzo Barone
GCGiovanni Chillemi
Giovanni Chillemi
NSNico Sanna
Nico Sanna
WMWolfram Meyer-Klaucke
Wolfram Meyer-Klaucke
NPNicolae Viorel Pavel
Nicolae Viorel Pavel

24 January 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
GCGiovanni Capranico
Giovanni Capranico
JMJessica Marinello
Jessica Marinello
GCGiovanni Chillemi
Giovanni Chillemi

1 January 2000 in The Journal of Chemical Physics
Verified
Journal Article
Closed access
PDF file
AAAndrea Amadei
Andrea Amadei
GCGiovanni Chillemi
Giovanni Chillemi
MCM. A. Ceruso
M. A. Ceruso
AGAlessandro Grottesi
Alessandro Grottesi
ANA. Di Nola
A. Di Nola
From a specific definition of the roto-translational (external) and intramolecular (internal) coordinates, a constrained dynamics algorithm is derived for removing the roto-translational motions during molecular dynamics simulations, within the leap-frog integration scheme. In the paper the theoretical basis of this new method and its statistical mechanical consistency are reported, together with two applications.

12 February 2009 in Retrovirology
Verified
Journal Article
Open access
PDF file
GRGABRIELLA ROZERA
GABRIELLA ROZERA
IAIsabella Abbate
Isabella Abbate
ABAlessandro Bruselles
Alessandro Bruselles
CVCrhysoula Vlassi
Crhysoula Vlassi
GDGianpiero D'OFfizi
Gianpiero D'OFfizi
MCMaria Capobianchi
Maria Capobianchi
Background: Virus-associated cell membrane proteins acquired by HIV-1 during budding may give information on the cellular source of circulating virions. In the present study, by applying immunosorting of the virus and of the cells with antibodies targeting monocyte (CD36) and lymphocyte (CD26) markers, it was possible to directly compare HIV-1 quasispecies archived in circulating monocytes and T lymphocytes with that present in plasma virions originated from the same cell types. Five chronically HIV-1 infected patients who underwent therapy interruption after prolonged HAART were enrolled in the study. The analysis was performed by the powerful technology of ultra-deep pyrosequencing after PCR amplification of part of the env gene, coding for the viral glycoprotein (gp) 120, encompassing the tropism-related V3 loop region. V3 amino acid sequences were used to establish heterogeneity parameters, to build phylogenetic trees and to predict co-receptor usage. Results: The heterogeneity of proviral and viral genomes derived from monocytes was higher than that of T-lymphocyte origin. Both monocytes and T lymphocytes might contribute to virus rebounding in the circulation after therapy interruptions, but other virus sources might also be involved. In addition, both proviral and circulating viral sequences from monocytes and T lymphocytes were predictive of a predominant R5 coreceptor usage. However, minor variants, segregating from the most frequent quasispecies variants, were present. In particular, in proviral genomes harboured by monocytes, minority variant clusters with a predicted X4 phenotype were found. Conclusion: This study provided the first direct comparison between the HIV-1 quasispecies archived as provirus in circulating monocytes and T lymphocytes with that of plasma virions replicating in the same cell types. Ultra-deep pyrosequencing generated data with some order of magnitude higher than any previously obtained with conventional approaches. Next generation sequencing allowed the analysis of previously inaccessible aspects of HIV-1 quasispecies, such as co-receptor usage of minority variants present in archived proviral sequences and in actually replicating virions, which may have clinical and therapeutic relevance.